173 related articles for article (PubMed ID: 18641541)
21. Systemic chemotherapy with cisplatin plus 5-FU (PF) for recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): efficacy and safety of a lower dose of PF (80/800) at a single institution in Japan.
Kiyota N; Tahara M; Kadowaki S; Fuse N; Doi T; Minami H; Ohtsu A
Jpn J Clin Oncol; 2009 Apr; 39(4):225-30. PubMed ID: 19211574
[TBL] [Abstract][Full Text] [Related]
22. A pharmacokinetic-based test to prevent severe 5-fluorouracil toxicity.
Bocci G; Barbara C; Vannozzi F; Di Paolo A; Melosi A; Barsanti G; Allegrini G; Falcone A; Del Tacca M; Danesi R
Clin Pharmacol Ther; 2006 Oct; 80(4):384-95. PubMed ID: 17015056
[TBL] [Abstract][Full Text] [Related]
23. Mitotic checkpoint genes, hsMAD2 and BubR1, in oesophageal squamous cancer cells and their association with 5-fluorouracil and cisplatin-based radiochemotherapy.
Tanaka K; Mohri Y; Ohi M; Yokoe T; Koike Y; Morimoto Y; Miki C; Tonouchi H; Kusunoki M
Clin Oncol (R Coll Radiol); 2008 Oct; 20(8):639-46. PubMed ID: 18691855
[TBL] [Abstract][Full Text] [Related]
24. [ERCC1 and TS expression in chemoradiotherapy treated esophageal squamous cell carcinoma].
Sobajima J; Haga N; Kumamoto K; Ishibashi K; Ishida H
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2394-6. PubMed ID: 21224584
[TBL] [Abstract][Full Text] [Related]
25. TNF-α -857C>T genotype is predictive of clinical response after treatment with definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma.
Omatsu H; Kuwahara A; Yamamori M; Fujita M; Okuno T; Miki I; Tamura T; Nishiguchi K; Okamura N; Nakamura T; Azuma T; Hirano T; Ozawa K; Hirai M
Int J Med Sci; 2013; 10(12):1755-60. PubMed ID: 24151445
[TBL] [Abstract][Full Text] [Related]
26. Long-term follow-up of a randomized Phase II study of cisplatin/5-FU concurrent chemoradiotherapy for esophageal cancer (KROSG0101/JROSG021).
Nishimura Y; Hiraoka M; Koike R; Nakamatsu K; Itasaka S; Kawamura M; Negoro Y; Araki N; Ishikawa H; Fujii T; Mitsuhashi N
Jpn J Clin Oncol; 2012 Sep; 42(9):807-12. PubMed ID: 22811410
[TBL] [Abstract][Full Text] [Related]
27. Prospective cohort comparison of neoadjuvant chemoradiotherapy versus chemotherapy in patients with oesophageal cancer.
Morgan MA; Lewis WG; Crosby TD; Escofet X; Roberts SA; Brewster AE; Harvard TJ; Clark GW
Br J Surg; 2007 Dec; 94(12):1509-14. PubMed ID: 17902093
[TBL] [Abstract][Full Text] [Related]
28. Myelotoxicity of preoperative chemoradiotherapy is a significant determinant of poor prognosis in patients with T4 esophageal cancer.
Miyoshi N; Yano M; Takachi K; Kishi K; Noura S; Eguchi H; Yamada T; Miyashiro I; Ohue M; Ohigashi H; Sasaki Y; Ishikawa O; Doki Y; Imaoka S
J Surg Oncol; 2009 Apr; 99(5):302-6. PubMed ID: 19170110
[TBL] [Abstract][Full Text] [Related]
29. Effects of plasma concentrations of 5-fluorouracil on long-term survival after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma.
Kuwahara A; Yamamori M; Kadoyama K; Nishiguchi K; Nakamura T; Miki I; Tamura T; Okuno T; Omatsu H; Sakaeda T
J Exp Clin Cancer Res; 2011 Oct; 30(1):94. PubMed ID: 21970688
[TBL] [Abstract][Full Text] [Related]
30. [Two cases of squamous cell carcinoma of the anal canal treated with chemoradiotherapy].
Sasaoka M; Fuwa N; Matsumoto A; Furutani K; Kamata M; Kodaira T
Gan To Kagaku Ryoho; 2001 Mar; 28(3):399-402. PubMed ID: 11265413
[TBL] [Abstract][Full Text] [Related]
31. [Effect of nedaplatin, 5-FU, and leucovorin combined with radiation therapy in unresectable esophageal carcinoma].
Futami R; Tajiri T; Miyashita M; Maruyama H; Makino H; Nomura T; Tateno A; Miyashita T; Sasajima K
Gan To Kagaku Ryoho; 2003 May; 30(5):681-4. PubMed ID: 12795101
[TBL] [Abstract][Full Text] [Related]
32. The telomere/telomerase binding factor PinX1 is a new target to improve the radiotherapy effect of oesophageal squamous cell carcinomas.
Qian D; Zhang B; He LR; Cai MY; Mai SJ; Liao YJ; Liu YH; Lin MC; Bian XW; Zeng YX; Huang JJ; Kung HF; Xie D
J Pathol; 2013 Apr; 229(5):765-74. PubMed ID: 23341363
[TBL] [Abstract][Full Text] [Related]
33. [Successfully treated case of hypopharyngeal and cervical esophageal squamous cell carcinoma with laryngeal preservation].
Okumura Y; Ryotokuji T; Miura A; Kato T; Tomemori T; Mitsuhashi T; Monma K; Izumi Y
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2385-7. PubMed ID: 21224581
[TBL] [Abstract][Full Text] [Related]
34. Antiemetic effect of ramosetron during hyperthermo-chemo-radiotherapy for esophageal cancer.
Morita M; Kuwano H; Ohno S; Kitamura K; Sugimachi K
Anticancer Res; 2000; 20(5C):3631-6. PubMed ID: 11268430
[TBL] [Abstract][Full Text] [Related]
35. Preoperative intensity-modulated radiotherapy and chemotherapy for locally advanced vulvar carcinoma.
Beriwal S; Coon D; Heron DE; Kelley JL; Edwards RP; Sukumvanich P; Zorn KK; Krivak TC
Gynecol Oncol; 2008 May; 109(2):291-5. PubMed ID: 18455637
[TBL] [Abstract][Full Text] [Related]
36. Association of VEGF genetic polymorphisms with prostate carcinoma risk and clinical outcome.
Sfar S; Hassen E; Saad H; Mosbah F; Chouchane L
Cytokine; 2006 Jul; 35(1-2):21-8. PubMed ID: 16908180
[TBL] [Abstract][Full Text] [Related]
37. Inflammation-based prognostic score, prior to neoadjuvant chemoradiotherapy, predicts postoperative outcome in patients with esophageal squamous cell carcinoma.
Kobayashi T; Teruya M; Kishiki T; Endo D; Takenaka Y; Tanaka H; Miki K; Kobayashi K; Morita K
Surgery; 2008 Nov; 144(5):729-35. PubMed ID: 19081014
[TBL] [Abstract][Full Text] [Related]
38. [Topical and systemic chemotherapy with 5-fluouracil in facial carcinoma secondary to xeroderma pigmentosum].
Khader A; Gritli S; Boussen I; Oueslati Z; Ferjaoui M; Nouira R; Ladgham A; Boussen H
Tunis Med; 2005 Nov; 83(11):672-4. PubMed ID: 16422364
[TBL] [Abstract][Full Text] [Related]
39. Epidermal growth factor receptor is a possible predictor of sensitivity to chemoradiotherapy in the primary lesion of esophageal squamous cell carcinoma.
Gotoh M; Takiuchi H; Kawabe S; Ohta S; Kii T; Kuwakado S; Katsu K
Jpn J Clin Oncol; 2007 Sep; 37(9):652-7. PubMed ID: 17940077
[TBL] [Abstract][Full Text] [Related]
40. Association of polymorphisms in vascular endothelial growth factor gene with the age of onset of amyotrophic lateral sclerosis.
Chen D; Shen L; Wang L; Lu A; Zhang H; Zhang X; Zhang Y; Shui W; Li L; Fan D; Zhang J
Amyotroph Lateral Scler; 2007 Jun; 8(3):144-9. PubMed ID: 17538775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
